bioAffinity Technologies Ratios (2021-2026) | BIAF

Ratios Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 88.82%87.30%92.54%90.55%93.75%74.97%24.78%34.61%41.29%38.73%29.24%26.21%19.92%34.84%43.49%
EBT Margin (Quarter) -6,742.11%-427,752.87%-71,380.39%-165,143.43%-8,793.12%-766.74%-107.12%-81.37%-87.79%-85.02%-134.40%-143.06%-317.59%-349.08%-196.78%-268.63%
EBIT Margin (Quarter) -52,382.77%-84,883.13%-69,213.17%-169,160.69%-9,009.78%-768.72%-105.83%-80.84%-87.08%-83.98%-133.47%-141.73%-198.16%-158.56%-196.94%-267.62%
EBITDA Margin (Quarter) -52,382.77%-84,813.57%-68,902.77%-166,806.19%-8,903.38%-753.61%-98.32%-79.22%-85.40%-82.26%-131.53%-139.37%-194.65%-155.47%-194.59%-265.82%
Operating Margin (Quarter) -52,382.77%-84,883.13%-69,213.17%-169,160.69%-9,009.78%-768.72%-105.83%-80.84%-87.08%-83.98%-133.47%-141.73%-198.16%-158.56%-196.94%-267.62%
Net Margin (Quarter) -6,742.11%-427,778.96%-71,380.35%-166,426.71%-8,816.36%-767.51%-107.22%-81.53%-88.01%-85.13%-134.40%-143.53%-319.88%-349.30%-196.98%-268.63%
FCF Margin (Quarter) -28,801.00%-153,052.26%-55,440.58%-169,528.23%-6,909.57%-513.49%-72.42%-99.21%-65.09%-73.12%-75.97%-91.31%-209.58%-171.27%-160.69%-239.20%
Efficiency
Inventory Average (Quarter) 0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.03M0.03M0.03M0.04M0.04M0.04M0.07M
Assets Average (Quarter) 13.12M11.32M9.67M9.53M9.21M8.14M7.35M6.60M6.53M6.03M5.15M8.15M11.25M9.45M
Equity Average (Quarter) -15.74M-16.26M-16.76M-2.09M11.82M10.36M8.88M7.55M5.92M5.06M4.35M3.28M2.86M2.02M-0.35M3.38M8.09M5.47M
Invested Capital (Quarter) -15.69M-7.01M-16.72M-16.79M22.00M11.30M9.84M8.14M8.28M6.06M6.37M4.45M4.05M3.44M2.18M-1.95M9.03M7.95M4.26M
Asset Utilization Ratio (Quarter) 0.000.000.030.280.610.991.421.431.461.490.830.550.60
Leverage & Solvency
Interest Coverage Ratio (Quarter) -3.89-1.03-1.71-1.09-18.19-941.37-0.00M-162.90-167.06-82.60-93.84-134.30-0.37M-169.66-5.21-597.25-6.66-404.67
Debt to Equity (Quarter) -0.010.040.020.020.010.000.010.010.010.03-0.020.000.010.01
Debt Ratio (Quarter) 0.150.040.020.020.000.000.000.000.000.010.010.000.000.00
Equity Ratio (Quarter) -10.870.900.910.920.910.690.590.650.520.480.400.26-0.450.770.660.46
Times Interest Earned (Quarter) -3.89-1.03-1.71-1.09-18.19-941.37-0.00M-162.90-167.06-82.60-93.84-134.30-0.37M-169.66-5.21-597.25-6.66-404.67
Valuation
Enterprise Value (Quarter) -1.36M-13.50M-11.41M-9.77M-8.30M-4.50M-2.82M-2.50M-0.80M-0.80M-1.11M-0.40M-0.80M-7.67M-6.45M-3.10M
Return Ratios
Return on Sales (Quarter) -0.67%-42.78%-7.14%-16.64%-0.88%-0.08%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.03%-0.03%-0.02%-0.03%
Return on Capital Employed (Quarter) -33.47%-46.00%-66.74%-95.80%-114.60%-131.38%-172.48%-202.99%-261.19%-368.46%-392.96%-179.34%-126.66%-184.46%
Return on Invested Capital (Quarter) -0.01%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%-0.03%-0.89%-0.03%-0.01%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%-0.01%-0.02%
Return on Equity (Quarter) 0.01%0.06%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.03%-0.03%-0.05%0.34%-0.04%-0.02%-0.03%